Leuprorelin and Triptorelin in the treatment of Prostate Cancer: Medication adherence, Persistence and Economic Evaluation in Five Years of Analysis : Table 1

Table 1: Summary of Submissions made to the Senate Committee for the Copyright Legislation Amendment (Fair Go For Fair Use) Bill 2013.

Drug	Leuprorelin 3.75 – 11.25
Years	2007		2008		2009		2010		2011		2012
Number of patients	78		77		94		123		132		206
Age
Median	85		84		83		82		81		81
Range	70	96	68	96	56	96	50	96	54	96	55	97
Drug	Triptorelin 3.75 – 11.25
Years	2007		2008		2009		2010		2011		2012
Number of patients	73		76		84		110		90		150
Age
Median	85		83		83		82		81		80
Range	62	94	62	94	62	94	62	94	60	93	57	94